Eutilex Co.,Ltd.
Eutilex - Model EU501 (HER2 x 4-1BB) -4-1BB mAb-based, Tumor Antigen
FromEutilex Co.,Ltd.
4-1BB mAb-based, tumor antigen targeting bispecific antibodies.
Most popular related searches
cancer antigen
in vivo efficacy
antigen targeting
antigen targeted
antigen target
cancerous target
cancer cell
antigen based
cancer drug
tumor specificity
Indication
HER2 positive solid cancer
Target /Drug class
Anti-human 4-1BB/HER2 mBsAb
Development Stage
Non-clinical
- Tumor cell-specific killing effect – low side effects
- Better efficacy for tumor clearance than monospecific antibody
